Sinopharm Group Co (HKSE:01099) Long-Term Debt : HK$17,144 Mil (As of Jun. 2024)

View and export this data going back to 2009. Start your Free Trial

What is Sinopharm Group Co Long-Term Debt?

Sinopharm Group Co's Long-Term Debt for the quarter that ended in Jun. 2024 was HK$17,144 Mil.

Sinopharm Group Co's quarterly Long-Term Debt declined from Jun. 2023 (HK$16,654 Mil) to Dec. 2023 (HK$15,131 Mil) but then increased from Dec. 2023 (HK$15,131 Mil) to Jun. 2024 (HK$17,144 Mil).

Sinopharm Group Co's annual Long-Term Debt increased from Dec. 2021 (HK$10,308 Mil) to Dec. 2022 (HK$13,122 Mil) and increased from Dec. 2022 (HK$13,122 Mil) to Dec. 2023 (HK$15,131 Mil).

Sinopharm Group Co Long-Term Debt Historical Data

The historical data trend for Sinopharm Group Co's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinopharm Group Co Long-Term Debt Chart

Sinopharm Group Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Long-Term Debt

Get a 7-Day Free Trial

10,572.55

10,308.40

13,121.88

15,131.38

9,221.73

Sinopharm Group Co Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Long-Term Debt	Get a 7-Day Free Trial															13,121.88	16,653.67	15,131.38	17,144.35	9,221.73

Sinopharm Group Co (HKSE:01099) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Sinopharm Group Co Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Sinopharm Group Co's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Sinopharm Group Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sinopharm Group Co Ltd (HKSE:01099) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

SHTDY:USA SHTDF:USA X2S:Germany X2S:Germany

Address

No. 385, East Longhua Road, Sinopharm Group Building, Huangpu District, Shanghai, CHN, 200023

Website

http://www.sinopharmgroup.com.cn

Founded in 2003, Sinopharm is the largest wholesaler and retailer of drugs and medical devices in China and listed on the Hong Kong Stock Exchange in 2009. It is a core subsidiary of China National Pharmaceutical Group. Sinopharm's largest operating segment is pharmaceutical distribution, making up over 70% of its total revenue by the end of 2023. In 2018, Sinopharm acquired the largest Chinese medical device distributor, China National Scientific Instruments and Materials. Now, medical device distribution accounts for over 20% of Sinopharm's total revenue. Sinopharm's downstream customers range from hospitals and other health services institutions to end-customers.

Executives

Lazard Asset Management Llc	2102 Investment manager
Jpmorgan Chase & Co.	2201 Interest of corporation controlled by you
Zhong Xin Zheng Quan Yun Fan Dan Yi Zi Chan Guan Li Ji Hua	2501 Other
Zhong Xin Zheng Quan Zi Chan Guan Li You Xian Gong Si	2102 Investment manager
Citic Securities Company Limited	2201 Interest of corporation controlled by you
Citigroup Inc.	2502 Approved lending agent
Fmr Llc	2201 Interest of corporation controlled by you
Blackrock, Inc.	2201 Interest of corporation controlled by you

Sinopharm Group Co Headlines

No Headlines